INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 275 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $355 | -7.3% | 9,302 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $383 | -28.3% | 9,302 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $534 | -18.6% | 9,302 | -20.5% | 0.00% | -25.0% |
| Q4 2022 | $656 | -99.9% | 11,702 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $496,000 | -21.5% | 11,702 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $632,000 | -16.0% | 11,702 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $752,000 | -19.8% | 11,702 | -16.4% | 0.00% | -20.0% |
| Q4 2021 | $938,000 | -2.2% | 14,002 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $959,000 | +0.4% | 14,002 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $955,000 | +4.7% | 14,002 | +6.1% | 0.01% | 0.0% |
| Q1 2021 | $912,000 | +6.4% | 13,202 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $857,000 | +37.6% | 13,202 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $623,000 | -49.8% | 13,202 | -50.0% | 0.01% | 0.0% |
| Q2 2020 | $1,240,000 | – | 26,404 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |